| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.125 | 2.672 | 76.332 | 85.394 | 101.654 | 147.511 | 222.786 | 215.184 | 193.986 | 13.358 |
| Total Income - EUR | 1.125 | 2.672 | 76.332 | 85.394 | 101.655 | 148.223 | 223.378 | 215.184 | 195.997 | 74.070 |
| Total Expenses - EUR | 7 | 335 | 4.270 | 5.442 | 24.012 | 24.690 | 27.334 | 31.470 | 66.301 | 62.925 |
| Gross Profit/Loss - EUR | 1.118 | 2.337 | 72.062 | 79.952 | 77.643 | 123.533 | 196.044 | 183.714 | 129.696 | 11.145 |
| Net Profit/Loss - EUR | 1.084 | 2.257 | 71.298 | 79.098 | 76.626 | 122.121 | 194.079 | 181.606 | 127.775 | 9.327 |
| Employees | 0 | 0 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gynecoland Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 271 | 0 | 0 | 0 | 108.632 | 100.969 | 84.409 | 72.553 | 56.596 | 0 |
| Current Assets | 892 | 2.331 | 72.271 | 94.234 | 76.886 | 127.380 | 210.574 | 193.841 | 141.231 | 9.795 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93 |
| Receivables | 0 | 0 | 0 | 645 | 28.071 | 105.242 | 170.382 | 163.621 | 113.946 | 2.775 |
| Cash | 892 | 2.331 | 72.271 | 93.590 | 48.815 | 22.139 | 40.192 | 30.220 | 27.285 | 6.927 |
| Shareholders Funds | 1.129 | 2.311 | 71.351 | 93.268 | 76.677 | 122.171 | 198.584 | 181.654 | 127.824 | 9.375 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 34 | 20 | 920 | 967 | 108.940 | 106.218 | 96.399 | 84.739 | 70.003 | 419 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gynecoland Srl